Application of Gemstone Spectral Computed Tomography Imaging in the Characterization of Solitary Pulmonary Nodules: Preliminary Result.

Objective: This study aimed to observe the value of computed tomography (CT) spectral imaging parameters in the diagnosis of solitary pulmonary nodules, during the contrast-enhanced early phase and late phase. Materials and Methods: This study was approved by the institutional review board and written informed consent was obtained from all patients. One hundred thirty-nine patients with solitary pulmonary nodules proved by pathology underwent double-phase enhanced CT scan using gemstone spectral imaging mode on a Discovery CT750 HD, and were divided into an active inflammatory group (43 cases), a malignant group (65 cases), and a tuberculosis group (31 cases). The slope rate was calculated from the spectral curve. Iodine concentrations (ICs) were derived from iodine-based material decomposition CT images and normalized to the IC in the aorta. The Kruskal-Wallis test and Nemenyi test were performed to compare quantitative parameters among the 3 groups or between each of the 2 groups. Results: There were significant differences in the slope rate, IC, and normalized IC (NIC) among the 3 groups. In the active inflammatory group, malignant group, and tuberculosis group, the mean slope rate were 3.03 +/- 0.71 (SD), 1.96 +/- 0.91, and 1.37 +/- 0.43, respectively, during the early phase and 3.28 +/- 0.67, 2.24 +/- 0.82, and 1.67 +/- 0.64, respectively, during the late phase. The ICs were 2.68 mg/mL +/- 0.56, 1.65 mg/mL +/- 0.76, and 1.10 mg/mL +/- 0.34, respectively, during the early phase and 2.79 mg/mL +/- 0.57, 1.90 mg/mL +/- 0.71, and 1.29 mg/mL +/- 0.44, respectively, during the late phase. The NIC were 0.24 +/- 0.06, 0.16 +/- 0.04, and 0.10 +/- 0.04, respectively, during the early phase and 0.57 +/- 0.10, 0.43 +/- 0.11, and 0.25 +/- 0.09, respectively, during the late phase. The mean slope rate, IC, and NIC for the active inflammatory group were significantly higher than these parameters for the malignant group (P

http://ift.tt/2bFQ1zj